Expanse Medical Welcomes Shlomi Nachman to Board of Directors

PLEASANTON, Calif., Aug. 21, 2023 /PRNewswire/ — Expanse Medical, the innovative medical device incubator founded by Eitan Konstantino with focus on global innovations, proudly announces the addition of Shlomi Nachman to its Board of Directors and the Board of its spinoff, Expanse ICE. Mr. Nachman’s distinguished career includes his recent tenure as Johnson & Johnson Company Group Chairman of Cardiovascular & Specialty Solutions and Vision.

As a hub for worldwide medical advancements, Expanse Medical has unwavering commitment to introducing next-generation medical solutions. In tandem with its partner, Genesis Medtech, the incubator remains at the cutting edge of the medical device landscape.

Eitan Konstantino, founder of Expanse Medical, conveyed his excitement, stating, “Our vision has always been to identify and nurture global medical innovations. With Shlomi joining our Board, we are fortifying our pledge. His unmatched experience will undoubtedly push us further in our global pursuits.”

Shlomi Nachman commented on his new role, “Innovation knows no boundaries, and I’m delighted to join an organization like Expanse Medical that’s dedicated to seeking and promoting advancements from all corners of the world.”

Warren Wang, CEO of Genesis Medtech, added, “Our partnership with Expanse Medical is underpinned by a shared dedication to global excellence. The addition of Shlomi reiterates our confidence in the transformative potential of our collaboration.”

Expanse Medical looks forward to the wealth of knowledge, expertise, and leadership Mr. Nachman will bring to the board.

About Expanse Medical:
Expanse Medical is a leading medical device hub founded by Eitan Konstantino. With a vision to disrupt the status quo, Expanse collaborates with industry leaders, clinicians, and academic researchers to identify and nurture cutting-edge medical technologies for global markets.

Subscribe on LinkedIn

Get the free newsletter

Subscribe to MedicaEx for top news, trends & analysis

We're committed to your privacy. MedicaEx uses the information you provide to us to contact you about our relevant content, products, and services. You may unsubscribe from these communications at any time. For more information, check out our Privacy Policy.

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

PR Newswire is solely responsible for the content of the above news submissions. If there are any violations of laws, violations of the membership terms of this website, or the risk of infringing on the rights of third parties, PR Newswire will be solely responsible for legal and damage compensation. Responsibility has nothing to do with MedicaEx.

Are you in?

Subscribe to receive exclusive content and notifications to your inbox

We're committed to your privacy. MedicaEx uses the information you provide to us to contact you about our relevant content, products, and services. You may unsubscribe from these communications at any time. For more information, check out our Privacy Policy.

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.